Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Jun

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Menu

Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

To read the full story....

Breaking News

AST Developer First Light Diagnostics Closes $4.5M Debt Financing

BD Files Patent Infringement Suit Against NeuMoDx

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Adaptive Biotechnologies Expects Planned IPO to Fetch $15 to $17 a Share

Featured White Papers

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

What's Popular?

Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics

BD Files Patent Infringement Suit Against NeuMoDx

Invitae to Acquire Singular Bio for $55M

Adaptive Biotechnologies Expects Planned IPO to Fetch $15 to $17 a Share

BD High-Throughput MDx System CE Marked

Sponsorships